Biotech News
ImmunityBio to Participate in UK Investor Conferences During London Life Sciences Week 2026
Senior leadership will discuss ImmunityBio’s clinical and commercial priorities at Jefferies Global Healthcare Conference and UBS Global Biopharma Conference in London CULVER CITY, Calif. --(BUSINESS WIRE)--Nov. 10, 2026-- ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company,
